Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in PGEN — Precigen, Inc.

CIK 1109448 NASHVILLE, TN
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,292,634
+$494,997 QoQ
Shares Held
226,778
+10.0% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. PGEN ranks #125 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in PGEN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,292,634 226,778
2026-03-31 $797,637 206,108
2025-12-31 $861,289 206,050
2025-09-30 $505,080 153,520
2025-06-30 $344,974 242,940
2025-03-31 $337,723 226,660
2024-12-31 $253,859 226,660
2024-09-30 $215,327 226,660
2024-06-30 $358,122 226,660
2024-03-31 $267,916 184,770
2023-12-31 $247,591 184,770
2023-09-30 $279,385 196,750
2023-06-30 $239,890 208,600
2023-03-31 $173,310 163,500
2022-12-31 $251,560 165,500
2022-09-30 $338,140 159,500
2022-06-30 $179,560 134,000
2022-03-31 $252,778 119,800
2021-12-31 $443,345 119,500
2021-09-30 $596,305 119,500
2021-06-30 $779,140 119,500
2021-03-31 $553,267 80,300
2020-12-31 $954,720 93,600
2020-09-30 $409,500 117,000
2020-06-30 $692,113 138,700
2020-03-31 $379,440 111,600